EPISODE · Jan 5, 2026 · 2 MIN
UK Secures Trump Trade Deal Exempting Pharmaceuticals and Wood Products from Steep US Tariffs
from United Kingdom Tariff News and Tracker · host Inception Point AI
Welcome to United Kingdom Tariff News and Tracker, your essential update on how US trade policies under President Trump are shaping Britain's economic landscape. In a major win for UK exporters, the Trump administration has struck a deal exempting British pharmaceuticals from new US tariffs, as reported by Politico. This agreement, reached earlier this month, shields the UK pharma sector from broader duties amid Trump's aggressive trade stance, potentially stabilizing supply chains and boosting competitiveness in the vital US market. Tocco Earth highlights another UK advantage: tariffs on finished wood products like upholstered furniture, kitchen cabinets, and vanities remain capped at just 10% for the UK—far below the 25% rates applied elsewhere and the postponed hikes to 30% or 50% delayed until January 2027. President Trump cited ongoing productive negotiations as the reason for the extension, preserving current pricing for UK firms through 2026. ING Think warns of uncertainty ahead, with the US Supreme Court poised to rule on Trump's emergency powers for country-level tariffs. Betting markets give 70-80% odds of a strike-down, which could slash average US tariff rates from 16-17% to under 10%, sparking refund scrambles—but Trump may pivot to a blanket 15% import tariff or sector-specific hikes. For the UK, this underscores the value of bilateral deals, especially as Economic Times notes US trade-weighted tariffs have eased to 27.4% from a 32.8% peak. On the horizon, VWv insights point to a US-UK tariff deal enhancing pharma reimbursement rates, rising from 9% to 12% by 2035, alongside a 15% cap on new medicines from 2026—a gamechanger for UK drugmakers. Meanwhile, affordability pressures may force Trump to cut tariffs further in 2026, per AOL Finance, easing the economic hangover from 2025's hikes. Tax Research UK speculates on Trump's Scotland fixation—golf courses, ancestral ties, and strategic assets like renewables and Faslane—amid his expansionist moves, though no direct tariff links yet. Stay tuned as negotiations evolve—the UK is carving out exemptions where others face barriers. Thank you for tuning in, listeners—please subscribe for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.
What this episode covers
Welcome to United Kingdom Tariff News and Tracker, your essential update on how US trade policies under President Trump are shaping Britain's economic landscape. In a major win for UK exporters, the Trump administration has struck a deal exempting British pharmaceuticals from new US tariffs, as reported by Politico. This agreement, reached earlier this month, shields the UK pharma sector from broader duties amid Trump's aggressive trade stance, potentially stabilizing supply chains and boosting competitiveness in the vital US market. Tocco Earth highlights another UK advantage: tariffs on finished wood products like upholstered furniture, kitchen cabinets, and vanities remain capped at just 10% for the UK—far below the 25% rates applied elsewhere and the postponed hikes to 30% or 50% delayed until January 2027. President Trump cited ongoing productive negotiations as the reason for the extension, preserving current pricing for UK firms through 2026. ING Think warns of uncertainty ahead, with the US Supreme Court poised to rule on Trump's emergency powers for country-level tariffs. Betting markets give 70-80% odds of a strike-down, which could slash average US tariff rates from 16-17% to under 10%, sparking refund scrambles—but Trump may pivot to a blanket 15% import tariff or sector-specific hikes. For the UK, this underscores the value of bilateral deals, especially as Economic Times notes US trade-weighted tariffs have eased to 27.4% from a 32.8% peak. On the horizon, VWv insights point to a US-UK tariff deal enhancing pharma reimbursement rates, rising from 9% to 12% by 2035, alongside a 15% cap on new medicines from 2026—a gamechanger for UK drugmakers. Meanwhile, affordability pressures may force Trump to cut tariffs further in 2026, per AOL Finance, easing the economic hangover from 2025's hikes. Tax Research UK speculates on Trump's Scotland fixation—golf courses, ancestral ties, and strategic assets like renewables and Faslane—amid his expansionist moves, though no direct tariff links yet. Stay tuned as negotiations evolve—the UK is carving out exemptions where others face barriers. Thank you for tuning in, listeners—please subscribe for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.
NOW PLAYING
UK Secures Trump Trade Deal Exempting Pharmaceuticals and Wood Products from Steep US Tariffs
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m